Forma Therapeutics (FMTX) PT Lowered to $62 at Credit Suisse, Following Clinical Update

March 30, 2021 11:32 AM EDT
Get Alerts FMTX Hot Sheet
Price: $18.36 +4.44%

Rating Summary:
    7 Buy, 0 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 16 | Down: 18 | New: 32
Trade Now! 
Join SI Premium – FREE

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.

Credit Suisse analyst Tiago Fauth lowered the price target on Forma Therapeutics (NASDAQ: FMTX) to $62.00 (from $68.00) while maintaining a Outperform rating.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

Analyst PT Change

Related Entities

Credit Suisse